Examine the public health and economic externalities of biodiversity loss, with reference to India's vulture population crash.
In this answer
Biodiversity loss is rarely confined to ecology; it imposes uncompensated costs on human health and the economy. India's Gyps vulture collapse — a 99%-plus decline driven by the veterinary painkiller diclofenac, which causes fatal kidney failure and visceral gout in scavenging birds [2] — is the sharpest available illustration of such externalities.
The ecological failure that triggers the externality
- Vultures are obligate scavengers; the Bombay Natural History Society recorded over 90% decline in white-rumped, long-billed and slender-billed vultures [2].
- Their loss removed India's free, near-instant carcass-disposal service, leaving carrion to rot, be dumped in water bodies, or be eaten by less efficient scavengers.
Public health externalities
- Surplus carcasses expanded feral dog and rat populations, amplifying rabies and water-borne disease transmission [1].
- A 2024 American Economic Review study estimates the collapse raised human mortality by over 4%, implying more than one lakh additional deaths annually [1].
- Burden falls hardest on rural, agrarian districts near unsafe carcass-disposal sites — a classic case of costs borne by those who never caused them.
Economic externalities
- Damages valued at about $69.4 billion per year, chiefly through premature mortality and disease burden [1].
- Costs are unpriced: the drug's market price never reflected the sanitation service destroyed — a textbook negative externality justifying regulatory intervention.
Policy response and residual gaps
- India banned veterinary diclofenac (2006), restricted multi-dose vials (2015), and framed a National Action Plan on Vulture Conservation, with breeding centres at Pinjore and Rajabhatkhawa [3].
- Yet electrocution and collision on expanding power lines is now an escalating threat, with vultures nesting at only half their historic sites [5]; low-cost fixes such as relocating carcass dumps away from high-tension lines have proven effective [4].
Internalising these costs demands treating vultures as public-health infrastructure: strict enforcement of NSAID bans, bird-safe transmission design through MoEFCC–Power Ministry convergence, and a One Health framework. Protecting a keystone scavenger is not charity to nature but the cheapest available investment in India's sanitation and human security.
Sources
- 1Frank & Sudarshan, "The Social Costs of Keystone Species Collapse: Evidence from the Decline of Vultures in India", *American Economic Review* 114(10), 20244%+ rise in human mortality, $69.4 billion/year damages, feral dog and water-pollution channels
- 2Government has Taken Steps to Protect Vultures, Press Information Bureaudiclofenac as cause of kidney failure in vultures, BNHS >90% decline, 2006 ban
- 3Environment Ministry Recommends Ban on Multidose Vial of Diclofenac to Save Vultures, Press Information Bureausingle-dose vial restriction (2015), National Action Plan (2006), Jatayu/Pinjore breeding centre
- 4Linear power infrastructure and vulture electrocution risk: mitigation through carcass dump relocation in Sudhauwala, Dehradun, *Journal of Threatened Taxa*carcass-dump relocation eliminated recorded electrocution mortality
- 5"Deadly span — India's power infrastructure is emerging as a big threat to vultures", The Hindu, 1 September 2026electrocution as emerging primary threat; 2025 survey showing 50% historic nesting-site occupancy